Review article: predictors of response to vedolizumab and ustekinumab in inflammatory bowel disease
Barré, A., Colombel, J.‐F., Ungaro, R.
Published in Alimentary pharmacology & therapeutics (01.04.2018)
Published in Alimentary pharmacology & therapeutics (01.04.2018)
Get full text
Journal Article
Systematic review: safety of mesalazine in ulcerative colitis
Sehgal, P., Colombel, J.‐F., Aboubakr, A., Narula, N.
Published in Alimentary pharmacology & therapeutics (01.06.2018)
Published in Alimentary pharmacology & therapeutics (01.06.2018)
Get full text
Journal Article
Long‐term efficacy and safety of ustekinumab for Crohn's disease through the second year of therapy
Sandborn, W. J., Rutgeerts, P., Gasink, C., Jacobstein, D., Zou, B., Johanns, J., Sands, B. E., Hanauer, S. B., Targan, S., Ghosh, S., de Villiers, W. J. S., Colombel, J.‐F., Feagan, B. G.
Published in Alimentary pharmacology & therapeutics (01.07.2018)
Published in Alimentary pharmacology & therapeutics (01.07.2018)
Get full text
Journal Article
Systematic review with meta‐analysis: proximal disease extension in limited ulcerative colitis
Roda, G., Narula, N., Pinotti, R., Skamnelos, A., Katsanos, K. H., Ungaro, R., Burisch, J., Torres, J., Colombel, J.‐F.
Published in Alimentary pharmacology & therapeutics (01.06.2017)
Published in Alimentary pharmacology & therapeutics (01.06.2017)
Get full text
Journal Article
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
Peyrin-Biroulet, L, Sandborn, W, Sands, B E, Reinisch, W, Bemelman, W, Bryant, R V, D'Haens, G, Dotan, I, Dubinsky, M, Feagan, B, Fiorino, G, Gearry, R, Krishnareddy, S, Lakatos, P L, Loftus, Jr, E V, Marteau, P, Munkholm, P, Murdoch, T B, Ordás, I, Panaccione, R, Riddell, R H, Ruel, J, Rubin, D T, Samaan, M, Siegel, C A, Silverberg, M S, Stoker, J, Schreiber, S, Travis, S, Van Assche, G, Danese, S, Panes, J, Bouguen, G, O'Donnell, S, Pariente, B, Winer, S, Hanauer, S, Colombel, J-F
Published in The American journal of gastroenterology (01.09.2015)
Published in The American journal of gastroenterology (01.09.2015)
Get full text
Journal Article
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications
Get full text
Journal Article
Conference Proceeding
Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease – a SONIC post hoc analysis
Colombel, J.‐F., Reinisch, W., Mantzaris, G. J., Kornbluth, A., Rutgeerts, P., Tang, K. L., Oortwijn, A., Bevelander, G. S., Cornillie, F. J., Sandborn, W. J.
Published in Alimentary pharmacology & therapeutics (01.04.2015)
Published in Alimentary pharmacology & therapeutics (01.04.2015)
Get full text
Journal Article
The features of mucosa‐associated microbiota in primary sclerosing cholangitis
Torres, J., Bao, X., Goel, A., Colombel, J.‐F., Pekow, J., Jabri, B., Williams, K.M., Castillo, A., Odin, J.A., Meckel, K., Fasihuddin, F., Peter, I., Itzkowitz, S., Hu, J.
Published in Alimentary pharmacology & therapeutics (01.04.2016)
Published in Alimentary pharmacology & therapeutics (01.04.2016)
Get full text
Journal Article
Factors associated with pregnancy outcome in anti‐TNF treated women with inflammatory bowel disease
Seirafi, M., Vroey, B., Amiot, A., Seksik, P., Roblin, X., Allez, M., Peyrin‐Biroulet, L., Marteau, P., Cadiot, G., Laharie, D., Boureille, A., De Vos, M., Savoye, G., Rahier, J.‐F., Carbonnel, F., Bonaz, B., Colombel, J.‐F., Bouhnik, Y.
Published in Alimentary pharmacology & therapeutics (01.08.2014)
Published in Alimentary pharmacology & therapeutics (01.08.2014)
Get full text
Journal Article
Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment: data from CHARM and ADHERE
Panaccione, R., Colombel, J.‐F., Sandborn, W. J., D'Haens, G., Zhou, Q., Pollack, P. F., Thakkar, R. B., Robinson, A. M.
Published in Alimentary pharmacology & therapeutics (01.11.2013)
Published in Alimentary pharmacology & therapeutics (01.11.2013)
Get full text
Journal Article
One‐year maintenance outcomes among patients with moderately‐to‐severely active ulcerative colitis who responded to induction therapy with adalimumab: subgroup analyses from ULTRA 2
Sandborn, W. J., Colombel, J.‐F., D'Haens, G., Van Assche, G., Wolf, D., Kron, M., Lazar, A., Robinson, A. M., Yang, M., Chao, J. D., Thakkar, R.
Published in Alimentary pharmacology & therapeutics (01.01.2013)
Published in Alimentary pharmacology & therapeutics (01.01.2013)
Get full text
Journal Article
The changing pattern of Crohn’s disease incidence in northern France: a continuing increase in the 10‐ to 19‐year‐old age bracket (1988–2007)
Chouraki, V., Savoye, G., Dauchet, L., Vernier‐Massouille, G., Dupas, J.‐L., Merle, V., Laberenne, J.‐E., Salomez, J.‐L., Lerebours, E., Turck, D., Cortot, A., Gower‐Rousseau, C., Colombel, J.‐F.
Published in Alimentary pharmacology & therapeutics (01.05.2011)
Published in Alimentary pharmacology & therapeutics (01.05.2011)
Get full text
Journal Article
Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn's Disease
Hoarau, G, Mukherjee, P K, Gower-Rousseau, C, Hager, C, Chandra, J, Retuerto, M A, Neut, C, Vermeire, S, Clemente, J, Colombel, J F, Fujioka, H, Poulain, D, Sendid, B, Ghannoum, M A
Published in mBio (20.09.2016)
Published in mBio (20.09.2016)
Get full text
Journal Article